152 related articles for article (PubMed ID: 32447821)
1. Advanced Merkel cell carcinoma-A focus on medical drug therapy.
Wollina U; Koch A; Cardoso JC
Dermatol Ther; 2020 Jul; 33(4):e13675. PubMed ID: 32447821
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Merkel Cell Carcinoma.
Nagase K; Narisawa Y
Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
[TBL] [Abstract][Full Text] [Related]
3. [Immune checkpoint inhibition in Merkel cell carcinoma].
Terheyden P; Mohr A; Langan EA
Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
[TBL] [Abstract][Full Text] [Related]
4. Current and preclinical treatment options for Merkel cell carcinoma.
Celikdemir B; Houben R; Kervarrec T; Samimi M; Schrama D
Expert Opin Biol Ther; 2023; 23(10):1015-1034. PubMed ID: 37691397
[TBL] [Abstract][Full Text] [Related]
5. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
[TBL] [Abstract][Full Text] [Related]
6. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
7. Modern diagnostics and treatment of Merkel cell carcinoma.
Weilandt J; Peitsch WK
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1524-1546. PubMed ID: 37875785
[TBL] [Abstract][Full Text] [Related]
8. Merkel Cell Carcinoma - Current Controversies and Future Directions.
Steven N; Lawton P; Poulsen M
Clin Oncol (R Coll Radiol); 2019 Nov; 31(11):789-796. PubMed ID: 31594644
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin.
Pectasides D; Pectasides M; Psyrri A; Koumarianou A; Xiros N; Pectasides E; Gaglia A; Lianos E; Papaxoinis G; Lampadiari V; Economopoulos T
Cancer Invest; 2006 Dec; 24(8):780-5. PubMed ID: 17162559
[TBL] [Abstract][Full Text] [Related]
10. Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacy.
Marchand A; Kervarrec T; Bhatia S; Samimi M
Expert Rev Anticancer Ther; 2020 Dec; 20(12):1093-1106. PubMed ID: 33044876
[TBL] [Abstract][Full Text] [Related]
11. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
Baker M; Cordes L; Brownell I
Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
[TBL] [Abstract][Full Text] [Related]
12. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma.
Fenig E; Brenner B; Katz A; Rakovsky E; Hana MB; Sulkes A
Cancer; 1997 Sep; 80(5):881-5. PubMed ID: 9307187
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Merkel cell carcinoma: a turning point in patient care.
Chan IS; Bhatia S; Kaufman HL; Lipson EJ
J Immunother Cancer; 2018 Mar; 6(1):23. PubMed ID: 29566749
[TBL] [Abstract][Full Text] [Related]
14. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy.
Veness MJ; Perera L; McCourt J; Shannon J; Hughes TM; Morgan GJ; Gebski V
ANZ J Surg; 2005 May; 75(5):275-81. PubMed ID: 15932436
[TBL] [Abstract][Full Text] [Related]
16. [Merkel cell carcinoma, role of radiotherapy and literature review].
Guihard S; Noël G
Cancer Radiother; 2009 Jan; 13(1):47-54. PubMed ID: 18718802
[TBL] [Abstract][Full Text] [Related]
17. Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy.
Chandra S; Zheng Y; Pandya S; Yu T; Kearney M; Wang L; Kim R; Phatak H
Future Oncol; 2020 Nov; 16(31):2521-2536. PubMed ID: 32883109
[No Abstract] [Full Text] [Related]
18. Recent Insights and Advances in the Management of Merkel Cell Carcinoma.
Banks PD; Sandhu S; Gyorki DE; Johnston ML; Rischin D
J Oncol Pract; 2016 Jul; 12(7):637-46. PubMed ID: 27407160
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
[TBL] [Abstract][Full Text] [Related]
20. Single-cell dissection of Merkel cell carcinoma heterogeneity unveils transcriptomic plasticity and therapeutic vulnerabilities.
Das BK; Kannan A; Velasco GJ; Kunika MD; Lambrecht N; Nguyen Q; Zhao H; Wu J; Gao L
Cell Rep Med; 2023 Jul; 4(7):101101. PubMed ID: 37421947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
